LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

    22/03/2021
    PRESS RELEASE

    EuropaBio and P-BIO launch the National Associations Council Summit 2021 - Building on Biotechnology: from vaccines to Economic Growth for Europe

    The National Associations Council of EuropaBio is pleased to launch its 2021 Summit ‘Building on Biotechnology: From vaccines to economic Growth for Europe’ being hosted on May 10.

    This inaugural Summit for the National Associations Council (NAC) will address how national priorities and synergies should be used to create an economic recovery pathway for Europe through biotechnology.

    The Covid crisis has created many precedents for the faster delivery of biotechnologies to market, and Europe now has a significant opportunity to continue this momentum across all sectors and ensure a competitive global position. Initiatives such as the European Health Emergency Preparedness and Response Authority (HERA), plus the Industrial and Circular Economy Strategies are all enablers for biotechnology and will be addressed in the Summit.

    The NAC Summit, jointly hosted with Portugal’s P-BIO in line with the current European Council Presidency, addresses its mission in two key sessions:

    Innovation and delivery for vaccine across countries and value chains Large companies SMEs and universities active in vaccine development will present how they were able to bring the vaccines to patient in unprecedented speed. They will share the enabling factors behind their collaboration and development, including partnering, finance, policy and regulation.

    Vaccine learning – Driving economic delivery with biotechnology SME presentations will demonstrate potential for the future, followed by a panel discussion with National Associations where priorities will be agreed for effective and impactful mobilisation of national resources to achieve a competitive Europe.

    The Summit will develop and publish a position for EuropaBio’s National Associations and use this as a roadmap in the Council’s work in supporting European development through national actions and synergies.

    Dr Claire Skentelbery, Director General of EuropaBio commented “Europe has a powerful engine to build competitiveness, through its Member and partner countries on the continent. This Summit reflects priorities and capabilities of countries of all sizes in Europe and helps to ensure that we all progress together”.

    Filipa Sacadura, Secretary General of P-BIO added “Portugal’s biotech sector is actively involved in vaccine development within global partnerships and this Summit reflects our own national priorities to further build on the economic power of biotechnology in the future”.

    REGISTER NOW!

    REGISTER HERE


    REGISTER HERE

    EuropaBio and P-BIO launch the National Associations Council Summit 2021


    Download
    2021_04_N_PR_EuropaBio-P-BIO-Launch-NAC-SummitDownload
    Share
    Communications Team
    Communications Team

    Related posts

    03/04/2026

    Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture


    Read more
    02/04/2026

    The EU Biotech Act II: A vital Act for biomanufacturing in Europe


    Read more
    31/03/2026

    Nestlé joins EuropaBio: Driving Innovation for Sustainable Food Systems


    Read more

    Important links

    • Pivot Bio joins EuropaBio: Advancing Innovation in Sustainable Agriculture
    • The EU Biotech Act II: A vital Act for biomanufacturing in Europe

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.